Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective studySong Chen, Wenbo Guo|Journal of Cancer Research and Clinical Oncology|2021Cited by 113